An interventional study of EQUIA Forte Fil and Clearfil Majesty Esthetic in Noncarious Cervical Lesions, sponsored by Recep Tayyip Erdogan University Training and Research Hospital. Withdrawn at 1 site in Turkey. Open to participants aged 20 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-05-06.
Sponsored by Recep Tayyip Erdogan University Training and Research Hospital · Not applicable, Interventional, and Treatment
To compare the clinical performance of high-viscosity glass ionomer, flowable composite, bulkfill composite and nanohybrid composite restorations in non-carious cervical lesions (NCCLs).
One hundred fourty NCCLs were randomised into four groups according to a split-mouth design. Clinical evaluations will be performed after 1 week, 3 months, 6 months, using FDI (World Dental Federation) criteria.
53 studies on the registry are indexed under Uterine Cervical Diseases; 11 are open to participants now.
Browse Uterine Cervical Diseases studies →Recep Tayyip Erdogan University Training and Research Hospital is the lead sponsor of 85 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: EQUIA Forte Fil
Other: NexComp Flow
Other: 3M Espe Bulk-fill
Other: Clearfil Majesty Esthetic
Apply cavity conditioner (20% polyacrylic acid) 10 s on enamel and dentine, rinse Mix 10 s and apply bulk-fill Apply EQUIA coat and light cure for 20 s unit
Apply in 2-mm increment, light cure for 20 s
Apply in 2-mm increment light cure for 20 s
Apply in single increment up to 4 mm; light curing for 20 s
evaluation of restoration on cervical lesions
According to FDI criteria (aesthetic, biological and fuctional) score 1, clinically very good; score 2, clinically good; score 3, clinically sufficient; score 4, clinically unsatisfactory; score 5, clinically poor. Scores 1-3 show clinically acceptable restoration, while scores 4 and 5 indicate failure
Time frame: 6 months
Plan to share: No — Data will be available within 1 years of study completion
No publications or documents are linked to this record.
This study is withdrawn, as verified in May 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Recep Tayyip Erdogan University Training and Research Hospital